Covalon Technologies Ltd. (OTCMKTS:CVALF - Get Free Report) saw a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 9,800 shares, a decline of 47.9% from the January 15th total of 18,800 shares. Based on an average trading volume of 42,100 shares, the short-interest ratio is presently 0.2 days.
Covalon Technologies Stock Down 1.2 %
CVALF traded down $0.03 during trading on Monday, hitting $2.11. The company's stock had a trading volume of 16,100 shares, compared to its average volume of 22,076. The stock has a market capitalization of $57.81 million, a price-to-earnings ratio of 30.15 and a beta of -0.29. The firm's 50 day moving average price is $2.25 and its two-hundred day moving average price is $2.31. Covalon Technologies has a 12 month low of $0.74 and a 12 month high of $3.08.
Covalon Technologies (OTCMKTS:CVALF - Get Free Report) last announced its quarterly earnings data on Tuesday, January 7th. The company reported $0.01 EPS for the quarter. Covalon Technologies had a return on equity of 12.33% and a net margin of 8.58%.
About Covalon Technologies
(
Get Free Report)
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.
Featured Stories
Before you consider Covalon Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Covalon Technologies wasn't on the list.
While Covalon Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
